翔宇医疗股价下跌2.27% 两款脑机接口设备获批年内推出

Core Viewpoint - Xiangyu Medical's stock price has experienced a decline, reflecting market volatility and investor sentiment towards the company's recent developments in rehabilitation medical devices [1] Company Overview - Xiangyu Medical's main business includes the research, production, and sales of rehabilitation medical devices, covering areas such as rehabilitation assessment, training, and therapy [1] - The company operates in sectors including medical devices, robotics concepts, and AI pharmaceuticals [1] Recent Developments - In June 2025, Xiangyu Medical received approval for two Class II medical device registration certificates that incorporate brain-computer interface technology [1] - The company plans to launch 20 to 30 related rehabilitation devices within the year [1] - In March 2025, the National Medical Insurance Administration included brain-computer interface technology as an independent billing item in its guidelines, providing policy support for commercialization in the industry [1] Market Activity - On August 14, 2025, Xiangyu Medical's stock price closed at 64.71 yuan, down 1.50 yuan or 2.27% from the previous trading day [1] - The stock opened at 65.66 yuan, reached a high of 68.98 yuan, and a low of 62.50 yuan, with a trading volume of 88,200 hands and a transaction amount of 574 million yuan [1] - The net outflow of main funds on August 14 was 11.01 million yuan, with a cumulative net outflow of 125 million yuan over the past five trading days [1]